Literature DB >> 23667302

Recent clinical and translational research on pediatric myocarditis.

Charles E Canter1, Madeleine W Cunningham, Leslie T Cooper.   

Abstract

Myocarditis is one of the most common causes of a pediatric dilated cardiomyopathy phenotype. While pediatric myocarditis is generally associated with resolution of myocardial dysfunction, approximately 30% of pediatric myocarditis patients will die or undergo heart transplantation. Cardiac magnetic resonance imaging is increasingly being utilized as the primary diagnositic modality in adult myocarditis. Animal studies and adult experience suggest that autoimmunity may contribute to cardiac dysfunction in myocarditis. These adult findings have yet to be evaluated fully in children, but may have an impact on the diagnosis and treatment of pediatric myocarditis in the future. The recent availability of pediatric specific ventricular assist devices may offer the potential for long-term support to allow for a greater chance for myocardial recovery.

Entities:  

Keywords:  Autoimmunity; Cardiomyopathy; Dilated cardiomyopathy; Myocarditis

Year:  2011        PMID: 23667302      PMCID: PMC3649092          DOI: 10.1016/j.ppedcard.2011.06.004

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN: 1058-9813


  43 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry.

Authors:  Susan R Foerster; Charles E Canter; Amy Cinar; Lynn A Sleeper; Steven A Webber; Elfriede Pahl; Paul F Kantor; Jorge A Alvarez; Steven D Colan; John L Jefferies; Jacqueline M Lamour; Renee Margossian; Jane E Messere; Paolo G Rusconi; Robert E Shaddy; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  Circ Heart Fail       Date:  2010-09-10       Impact factor: 8.790

6.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 7.  Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.

Authors:  Neil J Freedman; Robert J Lefkowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

9.  Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.

Authors:  M Giulia Gagliardi; M Bevilacqua; C Bassano; B Leonardi; R Boldrini; F Diomedi Camassei; A Fierabracci; A G Ugazio; G F Bottazzo
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

10.  Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Authors:  M W Cunningham; S M Antone; J M Gulizia; B M McManus; V A Fischetti; C J Gauntt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more
  1 in total

1.  Swainsonine protects H9c2 cells against lipopolysaccharide-induced apoptosis and inflammatory injury via down-regulating miR-429.

Authors:  Hongyan Lv; Su Zhang; Xiaohong Hao
Journal:  Cell Cycle       Date:  2019-12-26       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.